Ahmed El-Ghannam
(University of North Carolina at Charlotte, USA)

Dr. El-Ghannam is a highly creative biomaterials engineer with several US patents on the design of novel bioactive resorbable ceramics, coating bioceramics on Titanium and cobalt-chromium alloy and additive manufacturing of SiC and SCPC for space, military, and medical applications. The laboratory of Dr. EL-Ghannam got funds from DePuy J&J company, North Carolina Biotechnology center, DoD, NASA and others. Dr. El-Ghannam has successfully taken a novel resorbable bioactive ceramic (Shefabone SCPC) from the laboratory bench to the surgery room through FDA approval. He has many collaborators from universities, industry and medical institutes in US and worldwide. Dr. El-Ghannam has been a keynote speaker and a chair in national and international biomaterials conferences and has served as the associate editor of the JBMR-A for the last 16 years. He authored and co-authored biomaterials books and book chapters and have many publications in biomedical materials, engineering, dental and orthopedic journals. He was recognized recently by Stanford University in the list of the top 2% most widely cited scientists in Bioengineering.

Min Wang
(Department of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China)

Min Wang earned his BSc (1985) and PhD (1991) degrees in Materials Science and Engineering at Shanghai Jiao Tong University, China, and University of London, U.K., respectively. Dr.Wang is a tenured professor at The University of Hong Kong (HKU) since 2008. He has also been a Guest Professor or Adjunct Professor of several universities in mainland China (Shanghai Jiao Tong University, Zhejiang University, Tianjin University, Southwest Jiaotong University, South China University of Technology, etc.). As Programme Director, he led HKU’s interfaculty Medical Engineering Programme in 2013-2018. He is now an elected member of HKU’s Senate. Prior to joining HKU in 2003, Dr.Wang conducted research and teaching in universities in the UK (1991-1997), Singapore (1997-2002) and Hong Kong (2002-2003). For his achievements and contributions, he is elected a fellow of professional societies in the UK, Hong Kong, USA and internationally (FIMMM, 2001; FIMechE, 2007; FHKIE, 2010; FBSE, 2011; FAIMBE, 2012; WAC Academician, 2013; FRSC, 2020). His research interests include biomedical materials, tissue engineering, controlled release, and bionanotechnology. He has authored a large number of publications in peer-reviewed journals, books and conference proceedings. He has given many conference presentations, including over 190 invited talks at international conferences. He and his team have won many awards at international conferences. He has been developing new biomaterials using the composite/hybridization approach since 1991 and has been conducting tissue engineering research since 1999. The seminal research on bioactive bone analogue materials for bone substitution conducted in London by him and his colleagues in the 1990s were widely reported by the press (The Times in the UK, Chinese Science News in China, etc.). He is a leading researcher internationally on biomedical composite research and his work on biomedical composites has been widely cited by researchers in many countries. Dr.Wang and co-workers have also investigated various fabrication technologies for tissue engineering scaffolds, including freeze-drying, electrospinning and 3D printing, and the scaffolds developed are used to regenerate tissues such as bone, osteochondral tissue, blood vessel, peripheral nerve and gastrointestinal tract. His group also develops new materials and mechanisms for 4D printing in tissue engineering. He has authored chapters on 3D printing for authoritative books. Dr.Wang has been the Series Editor of Springer Series in Biomaterials Science and Engineering (http://www.springer.com/series/10955) books since 2012 and Editor or Associate Editor of journals (Progress in Materials Science, Medical & Biological Engineering & Computing, IET Nanobiotechnology, etc.). He served/serves in the Editorial Board of more than 20 international journals, including Journal of Materials Science: Materials in Medicine, Composites Science and Technology, Biomedical Materials, Biomaterials Research, and Journal of Orthopaedic Translation. Dr.Wang has served as Chair/Co-Chair and/or Organizer/Co-Organizer of 29 international conferences/symposia/workshops, including symposium/workshop in four World Biomaterials Congresses. Dr.Wang was/is an elected Council Member of Hong Kong Institution of Engineers, Chinese Society for Biomaterials (CSBM), Asian Biomaterials Federation, World Association for Chinese Biomedical Engineers (WACBE), and International Federation for Medical and Biological Engineering (IFMBE). Currently, he is also an elected member of the Steering Committee and Treasurer of IUS-BSE’s International College of Fellows.

Christine Knabe
(Philipps University Marburg, Germany)

Professor Christine Knabe is Professor of Experimental Orofacial Medicine at the dental school of the Philipps University Marburg, Germany. The focus of her work is on translational research from bench to bedside in the context of clinically relevant subjects in regenerative medicine and biomaterials research. Her research deals with various aspects of regenerative medicine, bone regeneration and bone tissue engineering utilizing bioactive resorbable bone grafting materials and 3D printed bioactive ceramic scaffolds in combination with 3D perfusion stem cell culture and microvascular techniques for segmental defect repair mainly in the context of implant dentistry and orthopaedics. From 1999 on, Professor Knabe built her own independent research program, specifically focusing on cellular reaction pathways triggered by the presence of bioactive implant materials and on translational research, which takes new biomaterials and therapeutic concepts for bone and tissue regeneration from basic research via preclinical studies involving large animal models and clinical trials to the clinical arena. These studies led to the FDA approval and clinical use of a novel bioactive silica containing calcium orthophosphate bone grafting material. Professor Knabe’s work furthermore deals with the effect of host factors on craniofacial bone regeneration with bioactive calcium phosphate bone grafts. This is in addition to collaborating with colleagues at University of Pennsylvania in the pursuit of much better treatments of resistant infections and with colleagues of the UNC at Charlotte on novel bioceramic urethral bulking agents.
Prof. Knabe obtained her DDS at the University of Göttingen, Germany, in 1988, and her PhD with Professor U. Gross in Berlin, Germany. After training in Oral Surgery and Periodontology at the University of Tübingen, she joined the Department of Prostodontics at the Free Universität Berlin in 1992. She complemented her training by various study periods abroad. In 1993, with Professor J. E. Davies at the University of Toronto, Canada; and in 1994. with Professor U. Belser at the University of Geneva, Switzerland, in clinical implant dentistry. From 1992-2010, she held various positions with increasing responsibilities in the departments of Prosthodontics (1992-1996), Periodontology (1996-1997), and was director of the division of Biomaterials and Dental Materials of the Dept. of Experimental Dentistry (1997-2010) at the Charité University Medical Center. 1999-2000 she spent a sabbatical with Prof. Rolfe Howlett at the Bone Biomaterial Unit of the University of New South Wales in Sydney, Australia to study molecular biological issues regarding implant-tissue interactions. Since 2007 she also has been visiting associate professor at the Division of Orthopaedic Surgery of the Thomas Jefferson University in Philadelphia (Director Prof. I. Shapiro). In January 2011, she joined the Philipps University Marburg, where she chairs the department of Experimental Orofacial Medicine. A very recent honor received by Professor Knabe from the Charité Foundation is the appointment as BIH (Berlin Institute of Health) visiting professor. In this context, Prof. Knabe closely collaborates with colleagues at the Charité University Medical Center and the Federal Institute for Materials Research in the pursuit of tissue engineered approaches for reconstruction of large segmental mandibular discontinuity defects resulting from tumor ablation.

Ahmed El-Ghannam
(University of North Carolina at Charlotte, USA)

Dr. El-Ghannam is a highly creative biomaterials engineer with several US patents on the design of novel bioactive resorbable ceramics, coating bioceramics on Titanium and cobalt-chromium alloy and additive manufacturing of SiC and SCPC for space, military, and medical applications. The laboratory of Dr. EL-Ghannam got funds from DePuy J&J company, North Carolina Biotechnology center, DoD, NASA and others. Dr. El-Ghannam has successfully taken a novel resorbable bioactive ceramic (Shefabone SCPC) from the laboratory bench to the surgery room through FDA approval. He has many collaborators from universities, industry and medical institutes in US and worldwide. Dr. El-Ghannam has been a keynote speaker and a chair in national and international biomaterials conferences and has served as the associate editor of the JBMR-A for the last 16 years. He authored and co-authored biomaterials books and book chapters and have many publications in biomedical materials, engineering, dental and orthopedic journals. He was recognized recently by Stanford University in the list of the top 2% most widely cited scientists in Bioengineering.

RANDA ALFOTAWI
(King Saud University, Saudi Arabia)

Randa Alfotawi is an Associate Professor & Clinical Consultant in Oral and Maxillofacial surgery. She received a Ph.D. in Bone and tissue engineering for a novel flap model for reconstructive surgery from the University of Glasgow, UK and MS. from the University of Glasgow, FDS RCS from Royal College of Surgeon Edinburgh. Her research specialty and interests include Regenerative Medicine/ Bone bioengineering using stem cells/ Bio-materials research, looking for innovative autogenous bone scaffolding. Her related publications include: Two book `s chapters”. Biomaterials for Oral and Craniomaxillofacial Applica Deb S(ed). Vol.17 Frontiers of Oral Biology (London, Karger publisher, 2015)”& Flap Techniques in Dentoalveolar Surgery Sridharan G(ed). Oral Disease.(Intechopen, 2020). Moreover, twenty-six other manuscript journal publications include which were published in high-rank scientific journals including Biomedical. Materials, Journal of Materials Science: Materials in Medicine, Materials, PLoS One, Journal of Tissue Engineering, Oral &Maxillofacial Surgery

Stuart Goodman
(Stanford University, USA)

Stuart B. Goodman MD MSc PhD FRCSC FACS FBSE FIOR FORS
Stuart B. Goodman is the Robert L. and Mary Ellenburg Professor of Surgery, and Professor with Tenure in the Department of Orthopaedic Surgery at Stanford University. He has a courtesy appointment in the Department of Bioengineering, and is a Fellow of the Institute of Chemistry, Engineering and Medicine for Human Health (ChEM-H). He was Chief of Orthopaedic Surgery from 1994-2002.

Dr. Goodman received his BSc, MD, and MSc from the University of Toronto, and his PhD from Lund University. Dr. Goodman's clinical practice concentrates on adult reconstructive surgery. His clinical research interests center on outcomes of joint replacements, juvenile arthritis, and osteonecrosis. His basic science interests include implant biocompatibility, inflammation, osteonecrosis, and musculoskeletal tissue regeneration and repair.

Dr. Goodman is former Chairman of the AAOS Biological Implants Committee, and former member of the AAOS Biomedical Engineering Committee. He is a member of the American, European, and International Hip Societies, Knee Society, AAHKS, and ARCO, a consultant to the FDA, and former vice-chairman of the Musculoskeletal Tissue Engineering study section at NIH. He was the President of the Society For Biomaterials (2001-2) and served on the Board of Directors of the Orthopaedic Research Society. Dr. Goodman is on the editorial board of numerous medical and bioengineering journals. Dr. Goodman has published over 600 peer-reviewed manuscripts. Dr. Goodman and co-workers have received numerous awards including the Clemson Award for Basic Research from the Society For Biomaterials in May 2000 and the Lifetime Achievement Award from the Association of Bone and Joint Surgeons.

Okhee Jeon
(Korea University, Korea, Republic of)

Dr. Ok Hee Jeon earned her Ph.D. degree in biomedical engineering in 2017 from Johns Hopkins University, where she conducted groundbreaking research on senescent cells and their contribution to the loss of musculoskeletal function after injury and as a consequence of aging. Her work led to the development of new regenerative and pharmacologic therapies that target these cells. She then joined the Buck Institute for Research on Aging as a postdoctoral researcher, where she discovered the phenomenon of senescence propagation as a new mechanism by which senescent cells rise with age and contribute to aging phenotypes, to a molecular level, identifying circulatory pro-aging proteins produced by senescent cells at the root of age-related diseases. She is now an assistant professor at the Korea University College of Medicine, where she is developing innovative therapies for aging and aging-related diseases by using engineering platforms to target senescent cells. In addition to her achievements in the field of aging, Dr. Jeon's expertise also includes biomarkers of cellular senescence and musculoskeletal aging.

Atsushi Mahara
(Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Japan)

My name is Atsushi Mahara. I was born in Japan and am now a Laboratory Chief at the National Cerebral and Cardiovascular Center Research Institute. When I was in the university, my research focused on nucleic acid chemistry and photoanalytical chemistry. After that, in my professional career, I have studied and developed cardiovascular devices based on tissue engineering and imaging technology. Especially, I have been interested in the preclinical application of decellularized artificial blood vessels and supramolecular MR contrast agents. I received the Young Investigation Award from the Japanese Society for Regenerative Medicine and the Society for Artificial Organs. My recent hobbies are reading, listening to and playing music, and walking with my dog.

Alireza Biglarnia
(Lund University, Sweden)

Dr. Biglarnia is an adjunct lecturer at Lund University and the medical director at the Department of Transplantation at Skåne University Hospital in Malmö, Sweden. His pre-clinical and clinical research is currently focused on the role of innate immunity in the mediation of graft injury in solid organ transplantation. Beyond academia, Dr. Biglarnia is also a co-founder of a pharmaceutical company developing novel therapeutics by combining engineering techniques to address injurious innate immune responses across a variety of medical conditions.

Naoki Morimoto
(Department of Plastic and Reconstructive Surgery, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Japan)

2019.5-present Professor, Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University
2016.12-2019.4 Associate professor, Department of Plastic and Reconstructive Surgery, Kansai Medical University
2011.4-2016.11　Senior Lecturer, Department of Plastic and ReconstructiveSurgery, Kansai Medical University
2005.4 Ph.D. Kyoto University Graduate School of Medicine
2004.4 –2011.3 Assistant professor, Department of Plastic and Reconstructive Surgery, Kyoto University
2003.4-2004.3 Fellow, Department of Plastic and Reconstructive Surgery, Kyoto University
2000.4-2003.3 Regular surgical staff, Kobe Municipal General Hospital
1998.3-2000.3 Fellow, Department of Plastic and Reconstructive Surgery, , Kyoto University
1996.4-1998.2 Regular surgical staff, Shimane Prefectural Central Hospital
1994.12-1996.3 Resident, Department of Plastic and Reconstructive Surgery, Shimane Prefectural Central Hospital
1993.5-1994.12 Resident, Department of Plastic and Reconstructive Surgery, Kobe Municipal General Hospital
1993.3 Graduated from Kyoto University School of Medicine

Arthur J. Coury
(Northeastern University, USA)

Arthur (Art) J. Coury
Member, National Academy of Engineering
American Chemical Society Fellow
University Distinguished Professor of Chemical Engineering
Northeastern University
artjcoury@aol.com
a.coury@northeastern.edu
617-834-9179

Dr. Art Coury holds a B.S. degree in chemistry from the University of Delaware (1962), a Ph.D. in organic chemistry (1965) and an M.B.A. (1980) from the University of Minnesota. His industrial career included positions as: Senior Research Chemist at General Mills, Inc. (1965-‐1976), Director, Polymer Technology and Research Fellow at Medtronic, Inc. (1976‐1993), Vice President, Research and Chief Scientific Officer at Focal, Inc. (1993‐2000), and Vice President, Biomaterials Research at Genzyme Corporation (2000‐2008). He currently is a consultant and academic professor. His career focus has been polymeric biomaterials for medical products such as implantable electronic devices, hydrogel‐based devices, and drug delivery systems. He holds over fifty-seven distinct patents and has published and presented widely in his field. His prior or current academic service has included adjunct or affiliate appointments at the University of Minnesota, the Harvard‐MIT Graduate Program in Health Sciences and Technology, the University of Cape Town, South Africa, the University of Trento, Italy, Sichuan University, China, Hebei University, China, and Northeastern University. His professional service has included: Chair, Minnesota Section, American Chemical Society (1989‐1990); President, Society for Biomaterials, USA (1999‐2000); President, American Institute for Medical and Biological Engineering (AIMBE) (2003‐2004) and membership on several universities, professional societies, and corporate advisory boards. His recent recognitions have included the delivery of distinguished lectureships, receipt of the 2007 Innovation and Technology Development Award of the Society for Biomaterials, being named as one of “100 Notable People in the Medical Device Industry” by MD&DI magazine (2008), induction into the National Academy of Engineering, USA (2009), recognition on the University of Delaware alumni “Wall of Fame” (2010), “The Man, the Myth, the Materials”, a symposium in honor of Art Coury’s 70th birthday (2010), induction as an American Chemical Society Fellow (2011), recipient of the Society for Biomaterials Founders’ Award (2012) and its C. William Hall Award (2013) of the AIMBE Pierre Galletti Award, the University of Minnesota Outstanding Alumni Award (2013), appointment as Honorary Professor, Sichuan University, Chengdu, China (2013) and Hebei University, Tianjin, China (2019), University Distinguished Professor at Northeastern University (2014), and recognition with the Directors’ Award of the Harvard/MIT Joint Program in Health Sciences and Technology (2016). A joint U.S/Japan Society for Biomaterials Symposium was held to honor 2 American and 2 Japanese Biomaterials Leaders in Hawaii (January 2022), with Art being an Honoree. In April, 2023, Art received the Society for Biomaterials Service Award and the American Chemical Society Division of Rubber Chemistry Bioelastomer Award.

Suping Lyu
(Medtronic Inc., USA)

Scientist at Medtronic PLC since 2020, expertise in polymer materials for medical devices.

Jing Liu
(Institute of Biomedical Engineering, Peking Union Medical College, Chinese Academy of Medical Sciences, China)

Jing Liu, Ph.D., Associate Professor, Master Supervisor, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences. In 2017, she graduated from the Department of Biomedical Engineering, Peking University; She studied in Cornell University as an exchange student during 2015-2016. She was selected in the Tianjin promotion plan "Young Science and technology outstanding talents" and Tianjin "131" innovative talent training project.
The research of cardiovascular biomaterials and the development of implant interventional medical devices is her major, including the development of transcatheter aortic valve products and polymeric tissue engineering valves. She has undertaken 14 scientific research projects, including two National Natural Science Foundation, two Tianjin Natural Science Foundation, one Tianjin Key Research and Development Plan. She published more than 20 SCI papers, including Biomaterials, Chemical Engineering Journal, Advanced Healthcare Materials, ACS Applied Materials & Interfaces, etc. She was authorized five Chinese invention patents and one utility model patent. She serves as the first member of the Cardiovascular Equipment Technical Committee of the Chinese Medical Equipment Association, the external expert of the Medical Device Technical Evaluation Center of the State Food and Drug Administration. Contact me: liujing@bme.pumc.edu.cn;

Ho-Wook Jun
(University of Alabama at Birmingham, USA)

Dr. Ho-Wook Jun is a Professor of the Department of Biomedical Engineering at the University of Alabama at Birmingham. Dr. Jun received Ph.D. in Bioengineering from Rice University in 2004. From 2004-2006, he was the Peter and Ruth Nicholas Postdoctoral Fellow at the Richard Smalley Institute for Nanoscale Science and Technology and in the Department of Chemistry at Rice University. Dr. Jun is a Co-Founder and a Chief Scientific Officer of Endomimetics, LLC. Dr. Jun’s research topics focus on understanding the essential principles of nanostructured biomaterials and their applications for medical devices and therapeutics. He has received numerous awards including Fellow of the American Heart Association (AHA), Early Career Award from the Wallace H. Coulter Foundation, Innovation Award from the American Diabetes Association, CAREER Award from the National Science Foundation (NSF), and Dean’s Award for Excellence in Mentorship.

Ho-Wook Jun
(University of Alabama at Birmingham, USA)

Dr. Ho-Wook Jun is a Professor of the Department of Biomedical Engineering at the University of Alabama at Birmingham. Dr. Jun received Ph.D. in Bioengineering from Rice University in 2004. From 2004-2006, he was the Peter and Ruth Nicholas Postdoctoral Fellow at the Richard Smalley Institute for Nanoscale Science and Technology and in the Department of Chemistry at Rice University. Dr. Jun is a Co-Founder and a Chief Scientific Officer of Endomimetics, LLC. Dr. Jun’s research topics focus on understanding the essential principles of nanostructured biomaterials and their applications for medical devices and therapeutics. He has received numerous awards including Fellow of the American Heart Association (AHA), Early Career Award from the Wallace H. Coulter Foundation, Innovation Award from the American Diabetes Association, CAREER Award from the National Science Foundation (NSF), and Dean’s Award for Excellence in Mentorship.

Juan Melero-Martin
(Boston Children's Hospital, USA)

Dr. Melero-Martin graduated in Chemical Engineering from the University of Seville, Spain, in 1998. After working for three years in Industry, he earned a Ph.D. in Biochemical Engineering from the University of Birmingham, UK, in 2005. He then trained as a post-doctoral fellow in the Vascular Biology Program at Boston Children's Hospital. In 2008, he joined the Department of Cardiac Surgery at Boston Children's Hospital to run a biomedical research laboratory. Currently, he is an Associate Professor of Surgery at Harvard Medical School, a principal faculty at the Harvard Stem Cell Institute, and the inaugural incumbent of an endowed Chair in Cardiac Surgery at Boston Children’s Hospital.

Dr. Melero-Martin’s research interest is primarily centered on bioengineering blood vessels. He investigates how vascular networks are formed from stem cell differentiation and has developed novel bioengineering applications with clinical translational potential. Dr. Melero-Martin strives to investigate questions that can have a long-lasting impact on regenerative medicine. His research goals are divided into four general categories:

1. Therapeutic revascularization of ischemic tissues (i.e., vascular cell therapy).
2. Engineering organ-specific vascular niches for tissue regeneration.
3. Genetically engineering vascular networks for drug delivery.
4. Vascularization of organoid systems.

Dr. Melero-Martin’s laboratory is a reference in human progenitor and pluripotent stem cell-derived vascular cells, areas in which he has contributed multiple original papers. His group has developed novel approaches to bioengineer vascular networks and has shown that bioengineered vascular networks can be used to harness the regenerative potential of other stem cells. In addition, his group developed a model that uses genetically engineered blood vessels to achieve the controlled release of therapeutic proteins in vivo.

Dr. Melero-Martin routinely collaborates and provides expertise to other laboratories in the US and abroad. People from other groups continue to come to his laboratory to learn about stem cell-derived vascular cells and models for building blood vessels. Dr. Melero-Martin has a track record of successfully obtaining funds from multiple sources, including the NIH, the private sector, foundations, and intramural support. The NIH has continuously funded him since 2009.

Fabien Kawecki
(University of Bordeaux, Inserm BioTis U 1026, France)

Fabien Kawecki, PhD, is a young researcher working at the laboratory for Bioengineering of Tissue (BioTis) at INSERM, University of Bordeaux, France. He completed his PhD in bone tissue engineering and microvascularization from Laval University in Quebec City, Canada. After that, he worked as an industrial Post-doc at Poietis Company in Pessac, France, where he developed a valvular tissue using a multimodal 3D bioprinting system (NGB). In 2019, He joined Dr. Nicolas L’Heureux’s research group at BioTis as a Post-doc to work on an ERC-granted project aimed at developing a new generation of woven tissue-engineered vascular grafts using Cell-Assembled extracellular Matrix (CAM) material. In 2021, he started his independent research program with the goal of developing completely biological strategies for cardiovascular surgical repairs, with a focus on using CAM material in pediatric cardiovascular applications (tetralogy of Fallot and Fontan procedures) to improve patient treatments. Fabien’s expertise covers tissue engineering of various connective tissues, including blood vessels, cardiac valves, bone, and skin. Email: fabien.kawecki@inserm.fr

Akari Seiner
(Drexel University, USA)

Akari J. Seiner is a third year PhD student studying Biomedical Engineering at Drexel University in the Tissue Instructive Materials Laboratory with Dr. Christopher Rodell. Her current research interests include pediatric and cardiovascular engineering, medical device development, and biomaterials. Her research project involves the development and characterization of covalently crosslinked photoresponsive hydrogels for use in pediatric heart reconstruction surgeries for newborns with single ventricle defects.

Evan Scott
(Northwestern University, USA)

Dr. Scott is the Kay Davis Professor of Biomedical Engineering at Northwestern University, where he established his research lab in 2013. He has a BS and PhD in Biomedical Engineering respectively from Brown university and Washington University in St. Louis and completed his postdoctoral work at the EPFL in Switzerland. Dr. Scott is a recipient of the NIH Director’s New Innovator Award, the National Science Foundation CAREER Award, the Biomedical Engineering Society Mid-Career Award, and is a fellow of the American Institute for Medical and Biological Engineering (AIMBE). His work has generated over 80 peer reviewed publications and 21 patent applications, some of which are the basis of his startup company SNC Therapeutics, where he serves as both the founder and CEO.

Yufeng Zheng
(Peking University, China)

Dr. Yufeng Zheng, received his Ph.D in materials science from Harbin Institute of Technology, China in 1998. From 1998 to 2004, he was Assistant Professor (1998-2000), Associate Professor (2000-2003), Full Professor (2003-2004) at Harbin Institute of Technology, China. He has been a full professor at the Peking University in Beijing, China since 2004, and Distinguished Professor at Kumamoto University, Japan since 2017. Dr. Zheng has authored or co-authored over 700 scientific peer-reviewed articles, with the citation of over 40000 times, and a H-index of 100. Currently he serves as Editor-in-Chief of “Bioactive Materials”, Vice Editor-in-Chief of “Journal of Materials Science & Technology”, Editor of “Materials Letters”. His areas of special interest include the development of new metallic biomaterials and their medical devices (biodegradable Mg, Fe and Zn based alloys, beta-Ti alloys with low elastic modulus, bulk metallic glass, ultra-fine grained metallic materials, etc). Dr. Zheng is the Fellow of American Institute for Medical and Biological Engineering (AIMBE) and Fellow of Biomaterials Science and Engineering (FBSE) by the International Union of Societies for Biomaterials Science and Engineering.

Jian Yang
(Westlake University, China)

Dr. Jian Yang is currently a Chair Professor in Biomaterials and Regenerative Engineering, the chair of Biomedical Engineering Program, and an Associate Vice President at the Westlake University. Prior to Westlake, he was a Professor of Biomedical Engineering and Dorothy Foehr Huck and J. Lloyd Huck Chair in Regenerative Engineering at the Pennsylvania State University. Dr. Yang is known for his pioneering contribution on citrate chemistry and biology for the development and applications of citrate-based biomaterials. He was a recipient of NSF CAREER Award (2010), Outstanding Young Engineering Faculty Award at UTA (2011), PSEAS Outstanding Research Award at Penn State (2018), and BMES Wallace H. Coulter Award for Healthcare Innovation Award (2023). Dr. Yang is an elected Fellow of American Institute of Medical and Biological Engineering (AIMBE, 2016), the National Academy of Inventors (NAI, 2018), the Biomedical Engineering Society (BMES, 2020), the American Association for the Advancement of Science (AAAS, 2021), and the International Academy of Medical and Biological Engineering (IAMBE, 2023). Dr. Yang is the Co-Editor-in-Chief of “Bioactive Materials”, and an Associate Editor of “Science Advances”. Dr. Yang is a co-founder and the Past-President of Chinese Association for Biomaterials (CAB) and the recipient of 2023 CAB Distinguished Leadership and Service Award. Dr. Yang co-founded a medical device company, Aleo BME, Inc. and is also serving on the Scientific Advisory Board of Acuitive Technologies, LLC.

Yi Hong
(University of Texas at Arlington, USA)

Dr. Yi Hong is a Distinguished University Professor in the Department of Bioengineering at the University of Texas at Arlington (UTA). He achieved his PhD in Material Science and Engineering in 2005 at Zhejiang University. Before joining the UTA in 2012, Dr. Hong worked as a postdoc and later as a Research Assistant Professor in the McGowan Institute for Regenerative Medicine in the University of Pittsburgh. His research focuses on developing functional and bioactive soft biomaterials and translational research for tissue repair and regeneration applications, especially for cardiovascular disease treatment, and women and children healthcare. He has published over 100 peer-review papers in the field of biomaterials and applied/issued 12 patents as well as over 160 conference abstracts. He received many awards, such as AHA Beginning Grant-in-Aid award (2014), NSF CAREER award (2016), College of Engineering Outstanding Early Career Award (2018), Junior Investigator Award from BMES ABioM-SIG (2018), CAB Mid-CAREER Award (2020), College of Engineering Excellence in Research Award (2020), University’s Outstanding Research Award (2021), and recent AHA Established Investigator Award (2022). He was elected as a Fellow of American Heart Association (AHA), American Institute for Medical and Biological Engineering (AIMBE), Royal Society of Chemistry (RSC), and Biomedical Engineering Society (BMES), and a Senior Member of National Academy of Inventors.

Patricia Holt-Torres
(University of California, Riverside, USA)

I received a BA and MS in Biology at California State University, San Bernardino. Currently, I am a Ph.D. Candidate in the Microbiology Program at the University of California, Riverside in the Huinan Liu laboratory, where I am focused on identifying antibacterial and antibiofilm properties of bioresorbable nanoparticles.

Riccardo Levato
(University Utrecht, Department of Biofabrication and Regenerative Medicine, Netherlands)

Riccardo Levato is Associate Professor of Translational Bioengineering and Biomaterials at the Department of Clinical Sciences (Faculty of Veterinary Medicine, Utrecht University), and at the Department of Orthopaedics of the University Medical Center Utrecht. He is also Principal Investigator at the Regenerative Medicine Center Utrecht. His work focuses on the development of novel biofabrication technologies for the generation of advanced in vitro tissue models and regenerative engineered tissues. His group developed high-performance light-based bioprinting techniques, including the first demonstration of volumetric bioprinting.
Prior to moving to Utrecht, he worked in several research groups across Europe: 3Bs, University of Minho (Portugal); BioMatLab, Technical University of Milan (Italy), Institute for Bioengineering of Catalonia (IBEC, Spain), and he holds a cum laude PhD in Biomedical Engineering from IBEC and from the Technical University of Catalonia. In 2020 he was awarded a Starting grant from the European Research Council on the development of a novel volumetric bioprinting technology for organoid research and to engineer functional bone marrow analogues in vitro. Since 2021, he is coordinator of a European consortium (ENLIGHT, Future and Emerging Technologies scheme, European Innovation Council pilot), aiming at developing biofabricated pancreas to study treatments for diabetes.

He published more than 70 peer-reviewed articles international journals, and he was conferred several awards including the 2016 Wake Forest Institute for Regenerative Medicine Young Investigator Award, the 2021 Jean Leray award from the European Society for Biomaterials, the 2022 Robert Brown award from the Tissue Engineering and Regenerative Medicine International Society, and the 2023 Mid-career Investigator Award from the International Society for Biofabrication (ISBF). Riccardo is also serving on the Board of Directors of ISBF.

Jos Olijve
(Rousselot Biomedical, Netherlands)

Scientific Support Manager at Rousselot Biomedical and among others responsible for biomedical co-developments with academia, CRO’s, Institutes and customers. Involved in product developments and creating background knowledge in particular determining the relationship between physical, chemical and purity properties of gelatin and different biomedical and pharmaceutical applications.
Also employed at FujiFilm, responsible for the development of photographic gelatins and besides this also involved in the development of recombinant gelatin and gelatin based peptides for both photographic and biomedical applications.
Holder of 16 patents/patent applications, and (co-)author of 16 scientific papers.
Holds a biochemical degree.

Ali Khademhosseini
(Terasaki Institute, USA)

Ali Khademhosseini is currently the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. At Harvard University, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials. Dr. Khademhosseini has served as an Associate Editor for ACS Nano from 2013 to 2021. He also served as the Research Highlights editor for Lab on a Chip. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS). He is also the recipient of the Mustafa Prize and is a member of the International Academy of Medical and Biological Engineering, Royal Society of Canada, Canadian Academy of Engineering, and National Academy of Inventors. He is an author on >700 peer-reviewed journal articles, editorials and review papers, >70 book chapters/edited books and >50 patents/patent applications. He has been cited >114,400 times and has an H-index of 174. He has made seminal contributions to modifying hydrogels and developing novel biomaterial solutions for addressing pressing problems in healthcare. He has founded 3 companies, Obsidio Medical which was recently acquired by Boston Scientific, Omeat and BioRAE. He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering.

Juyoung Park
(BioBricks, Korea, Republic of)

Dr. Ju Young Park completed her Ph.D. in the Division of Integrative Biosciences & Biotechnology (IBB) at Pohang University of Science and Technology (POSTECH) in 2016. Following her doctoral studies, she worked as a postdoctoral researcher at POSTECH from 2016 to 2019 and then pursued further research training as a postdoctoral research fellow at the Biologically Inspired Engineering Systems Laboratory at the University of Pennsylvania from 2019 to 2022.
Dr. Park has made significant contributions to her field, publishing over 30 peer-reviewed papers in prestigious journals within the domains of bioprinting and tissue engineering. Presently, she holds the position of Research Director at Biobricks, a startup company dedicated to tissue engineering utilizing decellularized extracellular matrix materials and 3D bioprinting technologies. In addition to her role at Biobricks, she also serves as a Research Professor in the Department of IT Convergence Engineering at POSTECH.
Her research interests are centered around pioneering innovative therapeutic solutions for transplantation within the human body, leveraging stem cells and tissue-derived natural biomaterials, as well as cutting-edge 3D bioprinting technology.

Jos Olijve
(Rousselot Biomedical, Netherlands)

Scientific Support Manager at Rousselot Biomedical and among others responsible for biomedical co-developments with academia, CRO’s, Institutes and customers. Involved in product developments and creating background knowledge in particular determining the relationship between physical, chemical and purity properties of gelatin and different biomedical and pharmaceutical applications.
Also employed at FujiFilm, responsible for the development of photographic gelatins and besides this also involved in the development of recombinant gelatin and gelatin based peptides for both photographic and biomedical applications.
Holder of 16 patents/patent applications, and (co-)author of 16 scientific papers.
Holds a biochemical degree.

NURUL AIDA NGAH
(Universiti Teknologi MARA, Malaysia)

I am a Malaysian Oral and Maxillofacial Surgeon and craniofacial biomaterial researcher from the Faculty of Dentistry, Universiti Teknologi MARA, Malaysia

Kyu Sang Joeng
(McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, USA)

Dr. Joeng has been an assistant professor in the Department of Orthopaedic Surgery at the University of Pennsylvania since 2018. Before Penn, he received his bachelor's in Biology from Yonsei University in 2000 and worked two more years at Yonsei University for a Master's Degree. He worked with Dr. Fanxin Long for his Ph.D. at Washington University in Saint Louis and joined Dr. Brendan Lee's lab for his postdoctoral training. The overall goal of his research program is to understand the pathophysiological mechanisms of musculoskeletal disorders, particularly related to the joint, such as osteoarthritis and tendon/ligament disorders.

Jung-Taek Hwang
(Department of Orthopedic Surgery, Cuncheon Sacred Heart Hospital, Hallym University Medical College, Korea, Republic of)

I am a specialist in shoulder and elbow Surgery, sports medicine, and arthroscopy. And I am interested in musculoskeletal biomechanics, regenerative medicine, and postoperatiove pain control.

Alicia El Haj
(University of Birmingham, United Kingdom)

https://www.birmingham.ac.uk/staff/profiles/chemical-engineering/el-haj-alicia.aspx

Mohd Fauzi MH Busra
(Universiti Kebangsaan Malaysia, Malaysia)

The enthusiasm for fabrication and 3D design of natural sources biomaterials, composites and hybrid bioscaffolds to mimic as much as possible its native tissue scaffold is core-business in my field of tissue engineering and regenerative research. Intervention of plant polyphenol from flavonoid for natural biomaterials that function as crosslinker. The introduction of various plant-based crosslinkers to enhance the strength and reduce the cytotoxic effect prior to cell seeding at later stage.

Molly Stevens
(Imperial College London, United Kingdom)

Prof Molly Stevens FREng FRS is John Black Professor of Bionanoscience at the University of Oxford and also holds part-time professorships at Imperial College London and the Karolinska Institute.
She graduated with a First-Class Honours BPharm degree from Bath University in 1995 and a PhD from the University of Nottingham in 2001. After postdoctoral research in the Langer Lab at MIT, she joined Imperial College London in 2004 as a lecturer and was promoted to Professor in 2008 as one of the youngest Professors ever in the history of the institution.
Molly’s multidisciplinary research balances the investigation of fundamental science with the development of technology to address some of the major healthcare challenges. She is a serial entrepreneur and the founder of several companies in the diagnostics, advanced therapeutics and regenerative medicine space. Her work has been instrumental in elucidating the bio-material interfaces. She has created a broad portfolio of designer biomaterials for applications in disease diagnostics and regenerative medicine. Her substantial body of work influences research groups around the world (>430 publications, h-index 104, >44k citations, 2018, 2021 and 2022 Clarivate Analytics Highly Cited Researcher in Cross-Field research).
Molly holds numerous leadership positions including Director of the UK Regenerative Medicine Platform "Smart Acellular Materials" Hub, Deputy Director of the EPSRC IRC in Early-Warning Sensing Systems for Infectious Diseases and Scientist Trustee of the National Gallery. She is Fellow of the Royal Society and the Royal Academy of Engineering (UK), Foreign Member of the National Academy of Engineering (USA) and International Honorary Member of the American Academy of Arts and Sciences.

Mohd Fauzi MH Busra
(Universiti Kebangsaan Malaysia, Malaysia)

The enthusiasm for fabrication and 3D design of natural sources biomaterials, composites and hybrid bioscaffolds to mimic as much as possible its native tissue scaffold is core-business in my field of tissue engineering and regenerative research. Intervention of plant polyphenol from flavonoid for natural biomaterials that function as crosslinker. The introduction of various plant-based crosslinkers to enhance the strength and reduce the cytotoxic effect prior to cell seeding at later stage.

Stuart Goodman
(Stanford University, USA)

Stuart B. Goodman MD MSc PhD FRCSC FACS FBSE FIOR FORS
Stuart B. Goodman is the Robert L. and Mary Ellenburg Professor of Surgery, and Professor with Tenure in the Department of Orthopaedic Surgery at Stanford University. He has a courtesy appointment in the Department of Bioengineering, and is a Fellow of the Institute of Chemistry, Engineering and Medicine for Human Health (ChEM-H). He was Chief of Orthopaedic Surgery from 1994-2002.

Dr. Goodman received his BSc, MD, and MSc from the University of Toronto, and his PhD from Lund University. Dr. Goodman's clinical practice concentrates on adult reconstructive surgery. His clinical research interests center on outcomes of joint replacements, juvenile arthritis, and osteonecrosis. His basic science interests include implant biocompatibility, inflammation, osteonecrosis, and musculoskeletal tissue regeneration and repair.

Dr. Goodman is former Chairman of the AAOS Biological Implants Committee, and former member of the AAOS Biomedical Engineering Committee. He is a member of the American, European, and International Hip Societies, Knee Society, AAHKS, and ARCO, a consultant to the FDA, and former vice-chairman of the Musculoskeletal Tissue Engineering study section at NIH. He was the President of the Society For Biomaterials (2001-2) and served on the Board of Directors of the Orthopaedic Research Society. Dr. Goodman is on the editorial board of numerous medical and bioengineering journals. Dr. Goodman has published over 600 peer-reviewed manuscripts. Dr. Goodman and co-workers have received numerous awards including the Clemson Award for Basic Research from the Society For Biomaterials in May 2000 and the Lifetime Achievement Award from the Association of Bone and Joint Surgeons.

Ching-Chang Ko
(Ohio State University, USA)

I am a dual trained clinician scientist. My job functions include teaching, research, and patient care. For the past 25 years, I have applied the fields of bioengineering in studying bone remodeling, bone marrow stromal cells, and medical artificial intelligence and utilized this combined knowledge to approach clinical problems, including biomaterials, bone reparation, bone disorders, and tooth movement. I have published more than 160 peer-reviewed articles. My laboratory has continually developed new biomaterials and factors that regulate bone remodeling. I have pioneered the synthetic process of hydroxyapatite-gelatin nanocomposites. I was previously funded by NIDCR (K08, R21, R43, R44, R01) to study bone regeneration using polydopamine-laced hydroxyapatite-gelatin scaffolds and to investigate mechanisms for dopamine-related osteogenesis.

Do-Gyoon Kim
(Ohio State University, USA)

Dr. Do-Gyoon Kim is a full Professor at Orthodontics, College of Dentistry, Ohio State University, Columbus, OH, USA. He was trained in biology for undergraduate at Yonsei University, Seoul, Korea. After obtaining master’s degree at the same institution, he started working in industry (Daewoo Co.), Korea. Rensselaer Polytechnic Institute (RPI), Troy, NY, USA marked his next stop in his professional development in the interdisciplinary field of basic science and applied engineering. His Ph.D dissertation focused intensively in biomechanics of the bone-implant interface from the microscopic point-of-view. Since finishing his Ph.D degree of Mechanical Engineering, he served as a post-doctoral researcher in SUNY Upstate Medical University, Syracuse, NY and as a research scientist and instructor at Bone and Joint Center at Henry Ford Hospital, Detroit, MI. After joining OSU, Dr. Kim has managed several grants including AAOF Biomedical Research Award, OSU seed grant, dental implant corporate grant, NSF and NIH grants. Based on these supports, he has published more than 100 full papers.

Hiroshi Kamioka
(Okayama University, Japan)

1993-1999
Assistant Professor in Dept. of Orthodontics, Tokushima University Dental School
(1995-1998)
Post-doctoral fellow in Dept. of Anatomy, Indiana University Medical School in USA
1999-2005
Lecturer in Dept. of Orthodontics, Okayama University Hospital
2005-2014
Associate Professor in Dept. of Orthodontics, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University.
2014-present
Professor in Dept. of Orthodontics, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University.
2015-present
Director in Okayama University Hospital Advanced Cleft Lip and Cleft Palate Treatment Center
2021-present
Vice Director in Okayama University Hospital

Jung Suk Han
(Seoul National University, Korea, Republic of)

Dr. Han is currently an Emeritus Professor in Department of Prosthodontics, School of Dentistry, Seoul National University. He graduated from School of Dentistry, Seoul National University 1983 and received MS degree in Prosthodontics from University of Michigan 1989. He served as a president of Korean Academy of Prosthodontics and Korean Academy of Digital Dentistry. He served as a dean for 4 years in School of Dentistry, Seoul National University. He is an immediate past co-president of International College of Prosthodontist (ICP) and a president of International Academy of Digital Dental Medicine(IADDM). He is a member of American Academy of Fixed Prosthodontics and former board member of American Equilibration Society.

Ching-Chang Ko
(The Ohio State University, USA)

I am a dual trained clinician scientist. My job functions include teaching, research, and patient care. For the past 25 years, I have applied the fields of bioengineering in studying bone remodeling, bone marrow stromal cells, and medical artificial intelligence and utilized this combined knowledge to approach clinical problems, including biomaterials, bone reparation, bone disorders, and tooth movement. I have published more than 160 peer-reviewed articles. My laboratory has continually developed new biomaterials and factors that regulate bone remodeling. I have pioneered the synthetic process of hydroxyapatite-gelatin nanocomposites. I was previously funded by NIDCR (K08, R21, R43, R44, R01) to study bone regeneration using polydopamine-laced hydroxyapatite-gelatin scaffolds and to investigate mechanisms for dopamine-related osteogenesis.

Takuya Matsumoto
(Okayama University, Japan)

Prof. Matsumoto graduated from Faculty of Dentistry, Osaka University and got DDS on 1997. Then he started dental biomaterials research and got PhD on 2002 from Osaka University. He is known as one of the leading designers of new dental-related biomaterials. His research approach is studying the hard tissue development with materials science perspective, and designing new materials based on the newly acquired understandings. Consequently, he has reported a three-dimensional in vitro model system that reproduce bone development from cell aggregates, developed technology for early bone regeneration/reconstruction, and has developed solid adhesives that has never existed before. Relating to these works, he has so far published more than 100 original papers (H index = 39) and submitted more than 15 patents relating to this field. He has received many important awards including Society Award and Young Investigator Award of Japanese Society for Biomaterials and Japanese Society for Dental Materials and Devices. Based on these achievements, he is currently active as a leader in Dental biomaterials, including executive director of the Japanese Society for Biomaterials and the Japanese Society for Dental Science and Technology, and director of the Japanese Association for Dental Research.

Jun-Beom Park
(The Catholic University of Korea, Korea, Republic of)

Dr. Jun-Beom Park was born in 1973 in Republic of Korea, where he obtained his degrees at Seoul National University (B.S., M.S. and Ph.D.). In 2008, he joined the Dr. Victor C. Yang's Lab at University of Michigan (Ann Arbor, MI, USA). He continued his postdoctoral fellowship at Seoul National University (Seoul, Korea). He continued his career at The Catholic University of Korea and he is working as a Full Professor at Department of Periodontics, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea. His main interests are the stem cell research, tissue engineering, dental implants and periodontitis.
Dr. Park is the member of the Korean Academy of Periodontology and he served as a Director of Publishing at the Korean Academy of Periodontology. He is currently working as an Associate Editor for Journal of Periodontal & Implant Science and an Editorial Board Member for Scientific Reports.
He has authored nine book chapters and he has published more than 100 original research papers. His papers were cited > 3,500 times. His major scientific contribution has been to enhance the bone regeneration using stem cells and growth factors, as well as to optimize the treatment of peri-implantitis.

Toru Deguchi
(University of Louisville, USA)

Dr. Toru Deguchi is a Professor and Chair of Department of Rehabilitative and Reconstructive Dentistry (Orthodontics and Prosthodontics) at the University of Louisville School of Dentistry. He completed his dental training at the Aichi-Gakuin University and received PhD at the Okayama University. He also had his orthodontic training at the Indiana University. He has been focusing his clinical interests in the field of temporary anchorage device (TADs), lingual orthodontics, and interdisciplinary cases. He has been also engaged in the research field such as histomorphometric studies related to tooth movement and pain related studies. Dr. Deguchi is a Diplomate of American Board of Orthodontics and a member of the Midwest Angle Society. Dr. Deguchi has lectured as invited speaker at the European Orthodontic Society, American Association of Orthodontics and in other international meetings all around the world.

Christine Hong
(UCSF, USA)

Christine Hong, D.M.D, M.S. is a Professor at the UCSF School of Dentistry. She currently serves as Interim Chair of the Division of Orthodontics and Program Director of Post-doctoral Orthodontic Residency at the UCSF School of Dentistry. Dr. Hong completed her dental education from the Harvard School of Dental Medicine and obtained her Orthodontics training at UCLA with a Certificate of Orthodontics and a Master's degree  in  Oral  Biology.  Dr. Hong is extensively involved in basic, translational, and clinical research and has received numerous awards from the AAOF, Cleft Palate Foundation, and NIH. Her research interests include epigenetics, stem cell fate determination, TMJ development, craniofacial regeneration, biomaterials for craniofacial tissues, and dental sleep medicine.

Josephine Wong
(Collagen Solutions, United Kingdom)

Senior Scientist at Collagen Solutions and have worked on projects including as part of the European Union’s Horizon 2020 research and innovation programme, and various internal and CDMO projects since joining in 2017. Collagen Solutions is a medical grade collagen material supplier and contract manufacturer.
My background is in Tissue Engineering and 3D tissue modelling based on type I collagen. I am particularly interested in researching the various techniques available to engineer and process collagen-based scaffolds for a clinically relevant material, and to assist in product development through scale-up. I currently work on the development of decellularised tissues for various potential applications.

Jinhui Huang
(Kunming Medical University, China)

PhD of Engineering, lecturer, master supervisor, Kunming Medical University. Selected as a young member of the Special Committee of Dentasl Materials of the Chinese Stomatological Association and the Xingdian Talent Program of Yunnan Province. Mainly engaged in soft and hard tissue regeneration for materialsoral and maxillofacial.Presided over 1 Fund project of National Natural Science Foundation of China, pesided over 4 provincial and and other projects, and published 15 relevant academic papers.

James Tsoi
(Hong Kong University, Hong Kong SAR, China)

Prof James Tsoi is an Associate Professor in Dental Materials Science and Assistant Dean (Innovation) at HKU Faculty of Dentistry. He received BSc in Applied and Analytical Chemistry and PhD in Dental Materials Science, from the University of Hong Kong. He also holds the Memberships of Royal Society of Chemistry (MRSC) and British Computer Society (MBCS), and Fellow in Advanced HE (FHEA). James is actively engaged in a number of research areas including: Dental materials science (mechanical behaviours, surface/bonding and ceramics), smart manufacturing (CAD/CAM and 3D printing), digital dentistry (AI and data science) and dental education (basic science and e-learning). He has authored more than 130 peer-reviewed journal articles, published and granted 10 patents, graduated 36 MSc and 11 PhDs, and been awarded 8 times in international conferences since he joined HKU Dentistry as a faculty member in 2012. He is currently serving several SCI journals’ editorial board (including Dental Materials), being President-elect in IADR-Dental Materials Group, Member-at-large in the Academy of Dental Materials, and Hong Kong head-of-delegate in ISO/TC 106 (Dentistry).

Seung Han Oh
(Wonkwang University, Korea, Republic of)

Seung Han Oh is a professor at the Department of Dental Biomaterials, School of Dentistry, Wonkwang University. His research focuses on developing new surface treatment technologies for dental/medical implants that exhibit excellent antibacterial activity and osseointegration with the help of different wavelengths of light.

James Tsoi
(Hong Kong University, Hong Kong SAR, China)

Prof James Tsoi is an Associate Professor in Dental Materials Science and Assistant Dean (Innovation) at HKU Faculty of Dentistry. He received BSc in Applied and Analytical Chemistry and PhD in Dental Materials Science, from the University of Hong Kong. He also holds the Memberships of Royal Society of Chemistry (MRSC) and British Computer Society (MBCS), and Fellow in Advanced HE (FHEA). James is actively engaged in a number of research areas including: Dental materials science (mechanical behaviours, surface/bonding and ceramics), smart manufacturing (CAD/CAM and 3D printing), digital dentistry (AI and data science) and dental education (basic science and e-learning). He has authored more than 130 peer-reviewed journal articles, published and granted 10 patents, graduated 36 MSc and 11 PhDs, and been awarded 8 times in international conferences since he joined HKU Dentistry as a faculty member in 2012. He is currently serving several SCI journals’ editorial board (including Dental Materials), being President-elect in IADR-Dental Materials Group, Member-at-large in the Academy of Dental Materials, and Hong Kong head-of-delegate in ISO/TC 106 (Dentistry).

Utkarsh Mangal
(Yonsei University College of Dentistry, Korea, Republic of)

Dr. Utkarsh Mangal is an Assistant Research Professor at the Institute of Craniofacial Deformity, Department of Orthodontics, Yonsei University College of Dentistry, Seoul, Korea. He has a B.D.S. and M.D.S. (Orthodontics) from Manipal College of Dental Sciences, Mangalore, India, and a Ph.D. (Dentistry) from Yonsei University College of Dentistry, Seoul, Korea. His research interests include dental biomaterials, microbial interaction, human microbiome, artificial intelligence, and craniofacial deformity. He was Marshalls' award finalist at the Academy of Dental Materials annual conference in 2023. He has published several papers in reputed journals and participated in various research projects funded by the Korean government and industry. He is the principal investigator for the project studying functionally customizable dental polymers with nanozyme application.

Siwei Li
(VSS Academy Training and Education Ltd, Imperial College London, United Kingdom)

Dr Siwei Li is experienced in research, public health, and business management. He currently holds a dual role at VSS Academy Training and Education Ltd. As the operations manager, Siwei oversees all aspects involved in the delivery of NHS England contracts, including new contract acquisition, finance, health and safety, inventory and premises, human resources, staff training and compliance. In his capacity as the head of research, Siwei established the R&D arm at VSS and led translational research efforts in the fields of implants, materials, and cell biology.

Siwei holds a bachelor's degree in Medical Engineering and an MSc in Nanotechnology and Regenerative Medicine. After completing his PhD in Tissue Engineering and Regenerative Medicine, Siwei joined Prof. Julian Jones’ Biomaterial Group as a post-doctoral research associate. Subsequently, he continued to develop his business and management skills at VSS.

Xinquan Jiang
(College of Stomatology, Shanghai Jiao Tong University, China)

Prof. Xinquan Jiang is now served as dean of faculty of dentistry, executive dean of college of stomatology, Shanghai JiaoTong University, academic leader of the department of prosthodontics, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, director of Shanghai Engineering and Research Center for Advanced Dental Technology and Materials and deputy director of National Center for Stomatology, executive vice-director of National Center for Stomatology, director of Shanghai Research Institute of Stomatology. Currently, he is also a distinguished professor at Shanghai Jiao tong University and an honorary professor at the University of Sydney (Faculty of Engineering and IT). He serves as president of ICP (International College of Prosthodontists) and fellow of ICD (international college of dentistry), vice president of Chinese Stomatological Association Council, vice president of Chinese Prosthodontic Society, councilor of Chinese Society for Biomaterials Council, and councilor of Chinese Society of Biomedical Engineering. Jiang was also invited as a member of the 8th subject consultative group, the Academic Degrees Committee of the State Council, and the editorial member of 5 International Journals.
Prof. Jiang’s research focuses on prosthodontics and regenerative medicine, particularly bone regeneration and oral function restoration, with tissue engineering and regenerative medicine strategies. He serves as the PI or Co-PI for more than 28 national or international grants and carries out clinical trials on evidence-based principles. He has 138 publications in peer-reviewed journals, including Advanced Materials, Advanced Science, Biomaterials, Journal of Dental Research, etc. He was invited for keynotes or invited lectures in national or international important meetings more than 20 times. He was involved in compiling 10 national planned teaching materials for the universities.
He won the prestigious IADR/Unilever Hatton Award in 2005 and was awarded by many national-level programs. He has long been engaged in teaching, guiding students to win awards, including the first International College of Prosthodontics "Research Assistance Programme" (ICP Research Grant Program, RGP) in 2016, the first prize of the Authur R Frechette 2016 new investigator award in the Prosthodontics Division and the Young investigator prize in the Oral Implantology Division, National Natural Science Foundation of China for Excellent Young Scholars, the Meiji Dairy Life Science Award, Young Ph.D. scholarship of Education Ministry, Young Elite Scientist Sponsorship Program by CAST, Shanghai Rising-star Program, and Sailing Program, etc.

Hala Zreiqat
(Biomaterials and Tissue Engineering Research Unit, School of Biomedical Engineering, Faculty of Engineering University of Sydney, Australia)

Hala Zreiqat, is a Payne-Scott Professor of biomedical engineering at The University of Sydney. The focus of her lab is on engineering functional synthetic biomaterials for use in regenerative medicine using cutting-edge materials, biological and nano techniques, and novel 3D-printing technologies.

Prof. Zreiqat’s contribution to regenerative medicine and orthopaedic research has led to a number of national and international awards, including being named a Member of the Order of Australia (2019), 2021-2022 Fulbright Senior Scholar; Laureate for the TAKREEM Foundation 2022 “Scientific & Technological Achievement”; the 2018 New South Wales Premier’s Woman of the Year, the King Abdullah II Order of Distinction of the Second Class (2018), Radcliffe Fellow at Harvard University (2016-2017); Eureka Prize winner for Innovative Use of Technology (2019); and University of Sydney Payne-Scott Professorial Distinction (2019). She is also a Fellow of the Australian Academy of Sciences (2021); the Australian Academy of Technology & Engineering (2020), the International Association of Advanced Materials (2022), the Royal Society of New South Wales (2019); Australian Academy of Health and Medical Sciences (2019), and the International Orthopaedic Research Society (2019). She is the past president of the Australian & New Zealand Orthopaedic Research Society. She was the Director of the Australian Research Council Training Centre for Innovative BioEngineering (2017-2022) and a National Health and Medical Research Council Senior Research Fellow (2006-2020). She is the Chair of the Council for Australian-Arab Relations (CAAR) (2020-2023); an Associate of the John A. Paulson School of Engineering and Applied Sciences at Harvard University and an Honorary Professor at Shanghai Jiao Tong University.

Prof. Zreiqat has authored over 180 peer-reviewed publications with over 10,000 citations. Her research in the field of musculoskeletal disorders and biomaterials research has led to four awarded and four provisional patents and more than $20.5M in competitive funding, including major grants from the National Health and Medical Research Council, Australian Research Council and the New South Wales Medical Devices Fund.
As well as her pioneering work in biomaterials development, Prof. Zreiqat is committed to improving opportunities for women and young scientists around the world. She is the founder and Chair of the BIOTech Futures, a science and engineering mentorship program for high school students.

Xinquan Jiang
(College of Stomatology, Shanghai Jiao Tong University, China)

Prof. Xinquan Jiang is now served as dean of faculty of dentistry, executive dean of college of stomatology, Shanghai JiaoTong University, academic leader of the department of prosthodontics, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, director of Shanghai Engineering and Research Center for Advanced Dental Technology and Materials and deputy director of National Center for Stomatology, executive vice-director of National Center for Stomatology, director of Shanghai Research Institute of Stomatology. Currently, he is also a distinguished professor at Shanghai Jiao tong University and an honorary professor at the University of Sydney (Faculty of Engineering and IT). He serves as president of ICP (International College of Prosthodontists) and fellow of ICD (international college of dentistry), vice president of Chinese Stomatological Association Council, vice president of Chinese Prosthodontic Society, councilor of Chinese Society for Biomaterials Council, and councilor of Chinese Society of Biomedical Engineering. Jiang was also invited as a member of the 8th subject consultative group, the Academic Degrees Committee of the State Council, and the editorial member of 5 International Journals.
Prof. Jiang’s research focuses on prosthodontics and regenerative medicine, particularly bone regeneration and oral function restoration, with tissue engineering and regenerative medicine strategies. He serves as the PI or Co-PI for more than 28 national or international grants and carries out clinical trials on evidence-based principles. He has 138 publications in peer-reviewed journals, including Advanced Materials, Advanced Science, Biomaterials, Journal of Dental Research, etc. He was invited for keynotes or invited lectures in national or international important meetings more than 20 times. He was involved in compiling 10 national planned teaching materials for the universities.
He won the prestigious IADR/Unilever Hatton Award in 2005 and was awarded by many national-level programs. He has long been engaged in teaching, guiding students to win awards, including the first International College of Prosthodontics "Research Assistance Programme" (ICP Research Grant Program, RGP) in 2016, the first prize of the Authur R Frechette 2016 new investigator award in the Prosthodontics Division and the Young investigator prize in the Oral Implantology Division, National Natural Science Foundation of China for Excellent Young Scholars, the Meiji Dairy Life Science Award, Young Ph.D. scholarship of Education Ministry, Young Elite Scientist Sponsorship Program by CAST, Shanghai Rising-star Program, and Sailing Program, etc.

Hala Zreiqat
(Biomaterials and Tissue Engineering Research Unit, School of Biomedical Engineering, Faculty of Engineering University of Sydney, Australia)

Hala Zreiqat, is a Payne-Scott Professor of biomedical engineering at The University of Sydney. The focus of her lab is on engineering functional synthetic biomaterials for use in regenerative medicine using cutting-edge materials, biological and nano techniques, and novel 3D-printing technologies.

Prof. Zreiqat’s contribution to regenerative medicine and orthopaedic research has led to a number of national and international awards, including being named a Member of the Order of Australia (2019), 2021-2022 Fulbright Senior Scholar; Laureate for the TAKREEM Foundation 2022 “Scientific & Technological Achievement”; the 2018 New South Wales Premier’s Woman of the Year, the King Abdullah II Order of Distinction of the Second Class (2018), Radcliffe Fellow at Harvard University (2016-2017); Eureka Prize winner for Innovative Use of Technology (2019); and University of Sydney Payne-Scott Professorial Distinction (2019). She is also a Fellow of the Australian Academy of Sciences (2021); the Australian Academy of Technology & Engineering (2020), the International Association of Advanced Materials (2022), the Royal Society of New South Wales (2019); Australian Academy of Health and Medical Sciences (2019), and the International Orthopaedic Research Society (2019). She is the past president of the Australian & New Zealand Orthopaedic Research Society. She was the Director of the Australian Research Council Training Centre for Innovative BioEngineering (2017-2022) and a National Health and Medical Research Council Senior Research Fellow (2006-2020). She is the Chair of the Council for Australian-Arab Relations (CAAR) (2020-2023); an Associate of the John A. Paulson School of Engineering and Applied Sciences at Harvard University and an Honorary Professor at Shanghai Jiao Tong University.

Prof. Zreiqat has authored over 180 peer-reviewed publications with over 10,000 citations. Her research in the field of musculoskeletal disorders and biomaterials research has led to four awarded and four provisional patents and more than $20.5M in competitive funding, including major grants from the National Health and Medical Research Council, Australian Research Council and the New South Wales Medical Devices Fund.
As well as her pioneering work in biomaterials development, Prof. Zreiqat is committed to improving opportunities for women and young scientists around the world. She is the founder and Chair of the BIOTech Futures, a science and engineering mentorship program for high school students.

Azam Ali
(University, New Zealand)

Professor Azam Ali, an internationally recognised biomaterial scientist, has strong research and teaching expertise in biomaterials and biomedical engineering. He obtained his PhD in biomaterials and bioengineering (2000) from USM. He worked at the Crown Research Institute (AgResearch, the largest New Zealand Govt. Research Organisation) as a senior scientist and research leader (2003-2013). He joined the University of Otago (UoO) in 2013 as associate professor and director of the Centre for Bioengineering and Nanomedicine (Dunedin Hub), at the Faculty of Dentistry, Division of Health Sciences. He has secured many national/International grants, worth NZ$12.5 million for 20+ projects. He has been leading (director) the bioengineering academic program at UoO, since 2014. He has published over 138 refereed articles, holds 24 Patents (21 granted as full patents), invented 6 medical devices (commercialising over 23 countries worldwide), 10+ Book chapters. He served as editor-in-chief (J. Mat Sci. & Eng.), and editorial board member of Bioactive Materials.

Maud Viallon
(Laval University, Canada)

Postdoctoral fellow in Biomaterials, my domain of expertise is in natural polymer-based hydrogels for biomedical applications. I earned a Master degree in polymer physico-chemistry in 2012 and a PhD in micro- nano-technologies and sensors in 2017. After that I undertook exploring the beautiful world of naturals polymers, and their applications in biomedicine especially regenerative medicine. My current research is focused on tuning properties of gels mainly from natural origin for new therapies for buccal diseases treatment/management. Passionate of cooking, nature, gardening and travelling, I like to express my creativity and discover new cultures (history, food...), ways of life and landscapes.